RapidAI celebrates one-millionth scan leveraging big-data to fuel AI and the future of stroke imaging

RapidAI celebrates one-millionth scan leveraging big-data to fuel AI and the future of stroke imaging

Press releases may be edited for formatting or style | July 28, 2020 Artificial Intelligence Cardiology Stroke
Rapid MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival
Rapid Mobile App: securely preview RapidAI results from multiple sites, receive notifications, and communicate about patient care, anytime, anywhere
“It is with great excitement that we honor Thomas Jefferson University Hospital for the one millionth recorded Rapid scan. In parallel, this builds on the over 1,600 hospitals in the U.S. and around the world that rely on RapidAI technology as an integral part of their stroke care every day,” said Don Listwin, CEO of RapidAI. “Also, with the aggregate data of over one million scans, along with predictive algorithms and our Rapid Insights analytics solution, we can help benchmark data, performance and clinical workflow for single hospital sites and whole networks, improving everyone’s stroke IQ.”

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

About RapidAI
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,600 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke patients using clinically proven, data-driven technology. With our validated, trusted platform, developed by stroke experts, clinicians worldwide are improving patient care and outcomes every day. The Rapid platform has been shown to aid in patient selection in both early and late-window clinical stroke trials. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, the results of these trials led to new American Heart Association and American Stroke Association treatment guidelines and have dramatically altered the management of acute stroke around the world.

Back to HCB News

You Must Be Logged In To Post A Comment